软组织肉瘤-瘤边缘透,免疫学标记物和生存率之间的相关性
Bogdan Șerban1,2, Adrian Cursaru1,2, Sergiu Iordache1,2
1Orthopedics and Traumatology, University Emergency Hospital, 050098 Bucharest, Romania.
International journal of molecular sciences
|May 14, 2025
概括
诊断软组织肉瘤 (STSs) 是一个挑战. 淋巴细胞标记物 (CD4,CD8,CD34) 在预测较少攻击性的瘤和更好的生存率方面表现有前途,有助于准确的诊断和治疗规划.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 免疫学 免疫学 免疫学
背景情况:
- 软组织肉瘤 (STSs) 由于患病率低和外表多样,因此存在诊断挑战.
- 准确的瘤边缘评估对于肢体的保存和患者的预后至关重要,但传统的MRI存在局限性.
- 区分瘤入侵和炎症透是很困难的,这凸显了对先进诊断工具的需求.
研究的目的:
- 为了研究软组织肉瘤中淋巴细胞透的预测价值.
- 通过扩散权重成像 (DWI) 评估的CD4,CD8和CD34表达与瘤边缘透的相关性.
- 澄清免疫标记在预测STS攻击性和患者结果中的作用.
主要方法:
- 使用扩散权重成像 (DWI) 来评估软组织肉瘤患者的瘤边缘透.
- 检查了瘤组织中CD4,CD8和CD34标记物的表达.
- 与DWI发现的瘤边缘透的相关标记表达.
主要成果:
- CD4,CD8和CD34标记的阳性与软组织肉瘤有关,这些肉瘤不会侵入瘤边缘.
- 这些标记物的积极表达表明瘤的攻击性较小.
- 具有CD4,CD8和CD34标志物阳性的患者表现出更高的生存率.
结论:
- 淋巴细胞透,以CD4,CD8和CD34阳性为指标,是较不具有攻击性的软组织肉瘤的显著预测因素.
- DWI与免疫标记分析相结合,可以改善瘤行为的评估和预后.
- 这些发现支持使用免疫标记物来提高诊断准确度,并指导STS的治疗策略.
相关概念视频
01:27Tumor Immunotherapy
441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K